| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | ELEVENS INC | Jun 22, 2026 | |
| Buy | Elevance Health, Inc. Common | Mar 27, 2026 | |
| Buy | ELEVANCE HEALTH INC. CMN | Jan 6, 2026 | |
| Buy | Elevance Health, Inc. Common | Dec 29, 2025 | |
| Sell | ELANCO ANIMAL HEALTH INCORPO | Sep 27, 2025 | |
| Sell | Elevance Health, Inc. Common | Aug 13, 2025 | |
| Buy | Elevance Health, Inc. Common | Aug 5, 2025 | |
| Buy | Elevance Health, Inc. Common | Jul 10, 2025 | |
| Buy | ELI LILLY & CO CMN | Jul 2, 2025 | |
| Buy | Elevance Health, Inc. Common | Jun 24, 2025 |
This page tracks congressional stock trading activity in Elevance Health, Inc. (ELV) in the Healthcare sector. Disclosed Capitol has indexed 72 disclosed congressional trades involving ELV. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 72 disclosed congressional trades in Elevance Health, Inc. (ELV) — 30:19 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jun 22, 2026 | Michael McCaul | R | Sell | $1,001 - $15,000 |
| Mar 27, 2026 | Alan Armstrong | R | Buy | $1,001 - $15,000 |
| Jan 6, 2026 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Dec 29, 2025 | Markwayne Mullin | R | Buy | $15,001 - $50,000 |
| Sep 27, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Aug 13, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Aug 5, 2025 | Gilbert Cisneros | D | Buy | $1,001 - $15,000 |
| Jul 10, 2025 | Lisa McClain | R | Buy | $1,001 - $15,000 |
| Jul 2, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Jun 24, 2025 | Lisa McClain | R | Buy | $1,001 - $15,000 |
Across the 72 disclosed congressional trades in Elevance Health, Inc. (ELV), members of Congress have reported 19 buys and 30 sells. The average 30-day alpha vs. the S&P 500 is -3.61%.
For fiscal year 2025, Elevance Health, Inc. reported revenue of $199.13B and net income of $5.66B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $50.47B, net income $1.46B.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.